Why is Roselabs Finance falling/rising?

As of 17-Jul, Roselabs Finance Ltd is currently priced at 30.00, reflecting an increase of 0.82 or 2.81%. The stock has recently shown a trend reversal, gaining after five consecutive days of decline. Despite this uptick, the stock has underperformed in the short term, with a one-week return of -7.12% compared to the Sensex's -1.12%. Additionally, while the stock is trading lower than all its moving averages, there has been a notable increase in investor participation, with delivery volume rising by 75.22% against the five-day average. However, the company faces significant challenges, including a negative book value and weak long-term fundamentals, as evidenced by a decline in profits by -16% over the past year.
In the broader market context, Roselabs Finance's recent performance contrasts sharply with the Sensex, which has shown a positive return of 0.83% over the past month. The stock's year-to-date performance is concerning, with a decline of -14.24% compared to the Sensex's gain of 5.27%. This underperformance highlights the stock's riskiness, particularly given its negative EBITDA and poor long-term growth metrics. Overall, while the stock has experienced a short-term rise, the underlying fundamentals and broader market trends suggest ongoing challenges for Roselabs Finance.